Pgk1的激活恢复了内皮的代谢平衡,以缓解血管衰老和动脉样硬化
Jinhong Lu1, Jianji Wang2, Yu Liu3,4
1Department of Biochemistry and Molecular Biology School of Basic Medicine, Capital Medical University, Youanmen, Beijing, 100069, China.
Cardiovascular diabetology
|November 8, 2025
概括
现在 (TZ) 通过通过独立于α1-AR信号的Pgk1/Hsp90/Prdx1通路抑制内皮细胞衰老来减少动脉样硬化和血管衰老. 这表明TZ可能是心脏代谢疾病的潜在老化剂.
科学领域:
- 心血管研究研究心血管研究
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 内皮功能障碍和氧化应激驱动心脏代谢疾病,如糖尿病和动脉样硬化.
- 持续的活性氧物种 (ROS) 加快内皮细胞 (EC) 衰老和屏障失效.
- 现在osin (TZ),一个α1-上腺素受体 (α1-AR) 抗剂,显示出在血管保护方面的潜力,但机制尚不清楚.
研究的目的:
- 调查TZ在预防ApoE-/-小鼠动脉样硬化的有效性.
- 阐明TZ血管保护作用的潜在分子机制.
- 要确定TZ是否独立于α1-AR信号的作用.
主要方法:
- 使用高胆固醇饮食中的ApoE-/-小鼠进行动脉样硬化模型.
- 在实验室中使用人类静脉初级EC (HUVEC) 的研究.
- 对EC衰老,ROS水平,血管透性和关键通路蛋白质 (Pgk1,Hsp90,Prdx1,VEGFA,血管静止素) 的分析.
主要成果:
- 在小鼠中,TZ显著降低了动脉样硬化斑块大小,EC衰老,血管透性和ROS水平.
- 通过Pgk1/Hsp90通路,TZ抑制了HUVEC中的EC衰老,增强了Hsp90-Prdx1相互作用并降低了ROS.
- TZ逆转了与衰老EC相关的VEGFA和血管静止素水平变化,降低了血管透性.
- 这些效应独立于α1-AR信号传输.
结论:
- TZ主要通过Pgk1/Hsp90/Prdx1通路缓解EC衰老和动脉样硬化.
- 通过TZ激活Pgk1,减轻内皮功能障碍和氧化应激,为糖尿病和其他心脏代谢疾病提供潜在的益处.
- TZ是治疗血管衰老和动脉样硬化的一种有前途的老化药物,针对Pgk1的疗法具有更广泛的意义.
相关概念视频
01:25cAMP-dependent Protein Kinase Pathways
8.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.3K
01:24Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
01:09GPCRs Regulate Adenylyl Cylase Activity
7.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.3K
01:22PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
01:10Mechanism of Angiogenesis
6.6K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.6K